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MORADY, F., ET AL.: Results of Catheter Ablation of Ventricular Tachycardia Using Direct Current
Shocks. Thirty-three patients with recurrent ventricular tachycardia (VT) underwent catheter ahlation
with direct-current shocks. One to four shocks 0/ 100-300 joules were deiivered to the presumed VT exit
sites as identified by endocardiai mapping and pace mapping. Fifteen patients (45%) had no recurrence 0/
symptomatic VT during a follow-up interval of 15.5 ± 10 months (mean ± standard deviation). Five
patients experienced six nonfatal complications (netv VTor ventricular jibriiJation, transient neuroiogical
deficit, atrioventricuiar hlock, brachial artery thrombosis). In conclusion, catheter ablation in selected
patients with recurrent VT has the potential for preventing recurrences 0/VT over the long-term and is
relatively safe. (PACE, Vol. 12, January Part II 1989)
ventricuiar tachycardia, endocardial mapping, catheter ablation
Introduction
Transcatheter direct current shocks deliv-
ered to the endocardium of the right or left ven-
tricle have at times been found to be effective in
preventing recurrences of ventricuiar tachycar-
dia (VT). The purpose of this report is to summa-
rize the results of attempted catheter ablation of
VT in 33 patients.
Methods
The subects of this report consist of 33 con-
secutive patients wbo underwent an attempt at
catheter ablation of VT at either Moffitt Hospital,
San Francisco or the University of Michigan Med-
ical Center between September 1982 and June
1986. Selection criteria included a history of re-
current, symptomatic, sustained VT and either
spontaneous or induced VT in the electrophysiol-
ogy laboratory wbich was hemodynamically
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stable and which could be mapped. In most cases,
patients had only a single configuration of VT.
There were 32 men and one woman, and
their mean age was 56 ± 14 years {± standard
deviation). The underlying heart disease con-
sisted of coronary artery disease in 22 patients,
idiopathic dilated cardiomyopathy in two pa-
tients, arrhythmogenic right ventricular dysplasia
in two patients, and tetralogy of Fallot that bad
undergone surgical repair in two patients. No
structural heart disease was present in five pa-
tients. Tbe mean left ventricular ejection fraction
was 0.34 ± 0.17. Nineteen of the 22 patients who
had coronary artery disease bad a ventricular an-
eurysm.
All patients had a history of symptomatic VT,
and the most severe symptom resulting from VT
consisted of a cardiac arrest in ten patients, syn-
cope in five patients, near syncope in 12 patients,
and palpitations and/or chest pain or dyspnea in
six patients. Thirteen patients had a history of
more than 25 episodes of VT, and 20 patients bad
a history of between two and 25 episodes. In eight
patients the VT was incessant for 3 to 7 days be-
fore the attempt at catheter ablation. All patients
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had been treated unsuccessfully with at least two
Class I antiarrhythmic drugs. Nineteen patients
were refractory to amiodarone. The mean num-
ber of total drug trials that were ineffective in
controlling VT before catheter ablation was 3.7
±1.2.
Electrophysiological Testing
Patients were studied in the fasting, unse-
dated state after they provided informed consent.
Antiarrhythmic drug therapy was discontinued
before the procedure in 18 patients and was con-
tinued in 15 patients who had had a partial re-
sponse to antiarrhythmic drug therapy. Two 6
French quadripolar electrode catheters were in-
serted into a femoral vein and positioned against
the right ventricular apex and outflow tract or
septum. A 6 French quadripolar electrode cath-
eter was inserted through a femoral or brachial
artery and positioned within the left ventricle.
Heparin was administered intravenously at an
initial dose of 3,000 units followed by 1,000 units
every hour. Electrocardiographic leads Vi, 1 and
III, the intracardiac electrograms, and a continu-
ous recording of the arterial pressure were dis-
played on an oscilloscope and recorded at a paper
speed of 100 to 150 mm/s. Programmed stimula-
tion was performed with a programmahle stimu-
lator. Whenever sustained VT that was hemody-
namically stable was induced, a 12-lead electro-
cardiographic recording was obtained.
Programmed ventricular stimulation was
performed with single, double and triple ventric-
ular extrastimuli at two right ventricular sites
using basic drive cycle lengths of 600, 500. or 400
ms. Sustained VT was defined as VT more than 30
seconds in duration or requiring direct-current
countershock for termination. Nonsustained VT
was defined as VT that was six complexes to 30
seconds in duration.
Mapping Technique
In each patient at least ten ventricular sites
were mapped. Whenever multiple morphologies
of VT were induced, the VT morphology that had
occurred spontaneously was mapped. Tbe endo-
cardial activation time at each mapping site was
defined as the interval between the first rapid de-
flection of the intracardiac electrogram and the
earliest deflection of the QRS complex in leads I,
III, or Vj during VT.
Pace mapping was performed by pacing at a
cycle length similar to the VT cycle length.
Twelve lead electrocardiograms were recorded
during pacing. However, pace mapping could not
be accomplished in seven patients because of the
inability to obtain ventricular capture with pac-
ing stimuli up to 20 mA in strength.
Pace maps were considered "excellent" if the
QRS complexes were identical or very similar to
the QRS complexes during VT in each of the 12
leads (Fig. 1). Pace maps were considered "good"
if the QRS complexes had the same bundle
branch block configuration and axis as the VT
and if the QRS complexes during pacing were
very similar to the QRS complexes during VT in
ten or 11 of 12 leads. If the QRS complexes during
pacing were very similar to the QRS complexes
during VT in no more than nine of 12 leads, the
pace map was considered "poor".
In the first ten patients in this series, shocks
were delivered at sites that had the earliest endo-
cardial activation during VT, without regard to
the results of pace mapping. However in subse-
quent patients shocks were delivered to sites at
which endocardial activation preceded the onset
of the QRS complex during VT and at which the
pace map was either good or excellent.
Catheter Ablation Technique
Tbe investigational protocol for catheter ab-
lation of VT was approved by the Human Re-
search Committee at the University of California,
San Francisco and the University of Michigan. A
previously unused 6 French quadripolar elec-
trode catheter (USCI, Billerica, MA, USA) with
either 0.5 or 1 cm between electrodes was posi-
tioned against the endocardium at the presumed
exit site of the VT. A 16-cm patch electrode (R2
Corporation) was positioned on the chest in the
closest possible proximity to the tip of the cath-
eter. The distal electrode of the catheter was con-
nected to the catbodal output of the defibrillator
and the patch electrode served as the anode. In
patients in whom the exit site of VT was in the
intraventricular septum, a catheter was posi-
tioned against each side of the septum, such that
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Figure lA. An example of an "excellent" pace map, with very similar QRS complexes during
ventricular tachycardia (VT] and during pacing at the right ventricular outflow tract (site 16) in
each of the 12 leads of the electrocardiogram. A. Frontai piane Jeads
the exit site of the VT was straddled. The distal
electrode of the left ventricular catheter served as
the cathode and the distal electrode of the cath-
eter on the right ventricular side of the septum
served as the anode.
Patients were anesthetized with either intra-
venous sodium thiopental or methohexitol.
Shocks that had a damped sinusoidal configura-
tion and a stored energy of 100 to 300 joules then
were delivered in synchronized fashion. Each pa-
tient received one to four shocks. Programmed
stimulation was performed 30 to 60 minutes after
the shocks were delivered to assess whether VT
was still inducible. After the procedure, patients
were monitored in the hospital and 1 week later,
an electrophysiologic study was repeated in pa-
tients who had not had inducible VT 30 to 60
minutes after the shocks. If VT was inducible, the
patients were treated with antiarrhythmic drugs
as guided by the results of electropharmacologic
testing.
Follow-Up
Follow-up information was obtained by in-
terviewing patients either in person or by tele-
phone. A successful outcome of catheter ablation
was defined as no recurrence of symptomatic VT
during follow-up, either in the absence of antiar-
rhythmic drug therapy, or while being treated
with the same antiarrhythmic drug regimen that
had been unsuccessful in controlling VT before
the ablation attempt.
Results
The mean VT cycle length was 412 + 91 ms.
The results of mapping indicated that the VT exit
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VT, CL 340 ms Pacing, CL 300 ms, site 16
1 sec
Figure IB. Precordial leads
site was in the left free wall in 13 patients, the
interventricular septum in nine patients, and the
right ventricle in 11 patients.
In 29 patients, an electrode positioned against
the endocardium served as the cathode and a
patch electrode on the chest wall was the anode.
One to four shocks were delivered in these pa-
tients, with a mean of 2.1 ± 0.8 shocks. The cu-
mulative stored energy of the shocks was 380
± 155 joules. Immediately after delivery of the
shocks in these patients, the clinical VT was still
inducible by programmed ventricular stimulation
in 11 of 29 patients. A monomorphic VT that had
not been observed clinically was induced in one
patient and no VT was induced in 17 patients.
During the follow-up electrophysiology test 1
week later, among the 17 patients in whom VT
was noninducible immediately after delivery of
the shocks, the original clinical VT was inducible
in three patients, a monomorphic VT that had not
been observed clinically was inducible in four pa-
tients, and no VT was inducible in ten patients.
Two transseptal shocks with a mean total stored
energy of 280 ± 75 joules were delivered in seven
patients in whom the exit site of VT was in the
interventricular septum. Immediately after deliv-
ery of the transseptal shocks, the clinical VT was
still inducihle in one of these seven patients, a
monomorphic VT that had not been observed
clinically was inducible in one patient, and no VT
was inducible in five patients. Among the six pa-
tients in whom the clinical VT was not inducible
immediately after delivery of the shocks, the fol-
low-up electrophysiology test 1 week later dem-
onstrated that the clinical VT was inducible in
three patients, a monomorphic VT that had not
been observed clinically was inducible in one pa-
tient, and no VT was inducible in two patients.
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Long-Term Follow-Up
The catheter ablation procedure was success-
ful in 15 of 33 patients. These patients had no
recurrence of symptomatic VT during a mean fol-
low-up interval of 15.5 ± 10 months. An addi-
tional three patients also did not have symptom-
atic VT during follow-up of 28 ± 20 months, how-
ever these patients were treated with an
antiarrhythmic drug regimen which had not been
used before delivery of the shocks.
Fifteen patients experienced a recurrence of
symptomatic VT during the follow-up period.
Ventricular tachycardia recurred anywhere be-
tween 1 day and 8 months after attempted cath-
eter ablation. The VT recurrence was nonfatal in
nine patients and fatal in six patients (mean fol-
low-up interval 9.8 ± 5 months).
The results of programmed ventricular stim-
ulation at the 1 week follow-up electrophysiology
test correlated with outcome. The follow-up elec-
trophysiology test demonstrated no inducible VT
in 67% of patients who had a successful outcome
and in only 11% of patients without a successful
outcome (P < 0.001). Age, underlying heart dis-
ease, left ventricular ejection fraction, and results
of mapping did not correlate with clinical out-
come. Patients with an unsuccessful outcome re-
ceived a greater number of shocks (2.4 ± 0.7 vs 1.7
± 0.6, P < 0.01). and a greater total number of
joules (410 ± 131 joules vs 304 ± 155 joules. P
Complications
The mean peak creatine kinase MB fraction
after the ablation procedure was 56 ± 65 iU/L
(normal range 0-10 IU/L). No patient developed
new Q waves on the electrocardiogram.
Five patients experienced six nonfatal com-
plications as a result of the catheter ablation pro-
cedure. The complications consisted of sustained
VT immediately postshock in one patient, ven-
tricular fibrillation on day 5 and day 6 postshock
in one patient, transient aphasia or hemiparesis in
two patients, transient 2:1 atrioventricular block
in one patient, atrioventricular block requiring a
permanent pacemaker in one patient who re-
ceived transseptal shocks, and a brachial artery
thrombosis in one patient. No patients experi-
enced a fatal complication.
Discussion
The long-term success rate of catheter abla-
tion in preventing recurrences of symptomatic VT
in the patients in this series was 45%. These re-
sults indicate that catheter ablation of VT may be
of value in the long-term management of selected
patients who have recurrent VT. Patients in this
series were selected to undergo catheter ablation
for the most part only if they had one configura-
tion of monomorphic VT that was hemodynami-
cally stable and could be adequately mapped. Al-
though such patients may represent a relatively
small subset of patients who have recurrent VT,
the catheter ablation procedure nevertheless may
be extremely useful in the management of these
patients if antiarrhythmic drug therapy is not ef-
fective. Many of the patients in this series were
not suitable candidates for endocardial resection
because of severely compromised left ventricular
function, and could not be managed successfully
with an antitachycardia pacemaker. In addition,
an automatic implantable cardioverter/defibril-
lator could not be used in many patients because
of frequent or incessant VT. Recurrences of VT
have been prevented by catheter ablation for up
to 35 months.
The catheter ablation procedure was found to
be relatively safe in this series, with no fatal com-
plications. There were no instances of myocardial
perforation or cardiac tamponade and 82% of pa-
tients did not experience any complication. Com-
plications that must be watcbed for include ven-
tricular tachycardia or ventricular fibrillation,
atrialventricular block, and cerebral ischemic
episodes.
In each patient, an endocardial site was iden-
tified at which activation during VT preceded the
onset of the QRS complexes. However, there was
no significant difference between the earliest ac-
tivation time in patients with and without a suc-
cessful outcome. There was no absolute value for
the endocardial activation time which predicted
success.
In regards to the value of pace mapping, the
success of the catheter ablation procedure ap-
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peared to be independent of whether the quality
of the pace map was "excellent" or "good". It ap-
pears that concordance between pacing and VT in
all 12 electrocardiographic leads is not necessary
for successful ablation of VT by transcatheter
sbocks. However, the results of this study do not
allow identification of the minimum number of
concordant leads required for successful out-
come.
Conclusions
Although catheter ablation of VT with intra-
cardiac shocks clearly is capahle of preventing re-
currences of monomorphic VT over the long-
term, its success rate is lower than the success
rate of map-directed or visually directed endo-
cardial resection. In patients with coronary artery
disease who have multiple configurations of VT.
endocardial resection may be appropriate if the
patient has a ventricular aneurysm and particu-
larly if there is an indication for coronary artery
bypass grafting. However, in patients who are
suboptimal candidates for endocardial resection
because of markedly compromised left ventricu-
lar function or the absence of a ventricular aneu-
rysm, the catheter ablation technique may pro-
vide a relatively low risk alternative to surgery
and may be indicated in drug refractory patients
who are not appropriate candidates for an anti-
tacbycardia pacemaker or automatic implantable
cardioverter/defibrillator
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